SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AB4. A total of 7 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 2.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $16,675,000 | – | 9,599,000 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 4,962,000 | $16,643,000 | 3.45% |
| Perceptive Advisors | 2,187,000 | $7,008,000 | 0.42% |
| Tekla Capital Management LLC | 2,000,000 | $6,655,000 | 0.24% |
| WELLS FARGO & COMPANY/MN | 25,000 | $80,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 50,000 | $166,000 | 0.00% |